Satish Valluri - Concepedia

Author

Satish Valluri

Janssen (United States)ORCID

Also Known As

S Valluri, S. Valluri, S.S. Valluri, Satish C Valluri, Satish Valluri

Publications

966

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Janssen (Belgium)UCSF Helen Diller Family Comprehensive Cancer Center Levine Cancer Institute Sarah Cannon

About

Satish Valluri is an author at Janssen (United States) specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	65
2	Immunology	2	2	53
3	Health Sciences	1	1	10
4	Autoimmunity	1	1	10
5	Cancer Epidemiology	1	1	12

Satish Valluri

Publications

753

Citations

H-Index

Page 1

	Year	Citations
A three-country comparison of psychotropic medication prevalence in youth Julie M. Zito, Daniel J. Safer, Lolkje TW de Jong-van den Berg, Child and Adolescent Psychiatry and Mental Health	2008	211
Psychotherapeutic Medication Prevalence in Medicaid-Insured Preschoolers Julie M. Zito, Daniel J. Safer, Satish Valluri, Journal of Child and Adolescent Psychopharmacology	2007	112
Impact of the 2004 Food and Drug Administration Pediatric Suicidality Warning on Antidepressant and Psychotherapy Treatment for New-Onset Depression Satish Valluri, Julie M. Zito, Daniel J. Safer, Medical Care	2010	61
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma Tom Martin, Saad Z. Usmani, Jordan M. Schecter, Current Medical Research and Opinion	2021	47
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma Luciano J. Costa, Yi Lin, Robert F. Cornell, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyVersus Conventional TreatmentMedicineImmunologyHematology	2021	43
Medical Costs Associated with Use of Systemic Therapy in Adults with Colorectal Cancer Brian Seal, Sean D. Sullivan, Scott D. Ramsey, Journal of Managed Care Pharmacy	2013	28
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma Thomas Martin, Amrita Krishnan, Kwee Yong, eJHaem	2021	28
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma Sundar Jagannath, N.R. Joseph, Concetta Crivera, Oncology and Therapy	2023	25
Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy Satish Valluri, Enrique Seoane‐Vazquez, Rosa Rodríguez-Monguió, BMC Health Services Research	2007	24
Illustrating the impact of mild/moderate and severe haemophilia on health‐related quality of life: hypothesised conceptual models Emuella Flood, Jennifer Pocoski, Lisa A. Michaels, European Journal Of Haematology	2014	22

Page 1